Coya Therapeutics Inc.
COYA | NASDAQ
$4.95
+$0.06 (+1.23%)
At close: Sep 21, 2026, 4:00 PM ET
$4.95
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $114.71M
Enterprise Value $-43.06B
Beta 0.62
Average Volume 178.1K
Shares Outstanding (Diluted) 23.46M
Shares Change YoY 40.25%
Institutional Ownership 35.91%
Exchange NASDAQ
ISIN US22407B1089
Price Performance
Price Change 1M 1.2%
Price Change 3M -8.2%
Price Change 6M 17.9%
Price Change YTD -12.4%
Price Change 1Y -9.5%
Price Change 3Y 23.1%
Price Change 5Y 4.5%
1M CAGR (ann.) 6.8%
1Y CAGR (ann.) -9.6%
5Y CAGR (ann.) N/A
All-Time CAGR 1.8%
Valuation
PE Ratio -4.63
Forward PE N/A
PEG Ratio -0.43
Forward PEG -0.57
PS Ratio 14.48
Forward PS 19.50
PB Ratio 0.00
P/FCF Ratio -0.01
P/Adj. FCF Ratio -0.01
P/OCF Ratio -0.01
EV/Sales -5,370.26
EV/EBIT 1,949.54
EV/EBITDA 1,951.25
EV/FCF 3.15
Earnings Yield -21.6%
FCF Yield -11783.1%
Adj. FCF Yield -14488.8%
Financial Health
Net Cash $43.18B
Total Debt $0
Cash & Short-Term Investments $43.18B
Total Assets $47.31B
Current Ratio 13.40
Quick Ratio 13.40
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -1.12
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 99.9%
Operating Profit Margin -282.3%
EBITDA Margin -275.2%
Net Profit Margin -270.2%
FCF Margin -170613.5%
Adj. FCF Margin -209789.8%
SBC / Revenue 39176.3%
SBC Impact (per share) -23.0%
Returns
Return on Assets -0.1%
Return on Equity -0.2%
Return on Invested Capital -0.1%
Return on Capital Employed -0.1%
Return on Tangible Assets -0.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -12.8%
Revenue CAGR 5Y 45.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -15.2%
EPS CAGR 5Y 3.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y -149.7%
FCF CAGR 5Y -99.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y -37.7%
Revenue Growth Next 3Y -50.0%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12
Price Target Upside 142.4%
Cash Flow
Operating Cash Flow $-13.68B
Free Cash Flow $-13.68B
Adj. Free Cash Flow $-16.82B
FCF Per Share -$583.26
OCF Per Share -$583.30
OCF/S Ratio -170624.5%
Income Statement
Revenue $8.02M
Gross Profit $8.01M
Operating Income $-22.63M
EBITDA $-22.07M
Net Income $-21.67M
EPS (Diluted) -$1.07
Revenue / Employee $1M
Profit / Employee $-2.71M
Employees 8
Add to Watchlist
Select watchlists to add or remove COYA